Literature DB >> 16704206

Synthesis of a biotin derivative of iberiotoxin: binding interactions with streptavidin and the BK Ca2+-activated K+ channel expressed in a human cell line.

Jon-Paul Bingham1, Shumin Bian, Zhi-Yong Tan, Zoltan Takacs, Edward Moczydlowski.   

Abstract

Iberiotoxin (IbTx) is a scorpion venom peptide that inhibits BK Ca2+-activated K+ channels with high affinity and specificity. Automated solid-phase synthesis was used to prepare a biotin-labeled derivative (IbTx-LC-biotin) of IbTx by substitution of Asp19 of the native 37-residue peptide with N--(D-biotin-6-amidocaproate)-L-lysine. Both IbTx-LC-biotin and its complex with streptavidin (StrAv) block single BK channels from rat skeletal muscle with nanomolar affinity, indicating that the biotin-labeled residue, either alone or in complex with StrAv, does not obstruct the toxin binding interaction with the BK channel. IbTx-LC-biotin exhibits high affinity (KD = 26 nM) and a slow dissociation rate (koff = 5.4 x 10(-4) s(-1)) in a macroscopic blocking assay of whole-cell current of the cloned human BK channel. Titration of IbTx-LC-biotin with StrAv monitored by high performance size exclusion chromatography is consistent with a stoichiometry of two binding sites for IbTx-LC-biotin per StrAv tetramer, indicating that steric interference hinders simultaneous binding of two toxin molecules on each of the two biotin-binding faces of StrAv. In combination with fluorescent conjugates of StrAv or anti-biotin antibody, IbTx-LC-biotin was used to image the surface distribution of BK channels on a transfected cell line. Fluorescence microscopy revealed a patch-like surface distribution of BK channel protein. The results support the feasibility of using IbTx-LC-biotin and similar biotin-tagged K+ channel toxins for diverse applications in cellular neurobiology. .

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16704206      PMCID: PMC2505059          DOI: 10.1021/bc060002u

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  66 in total

1.  Modulation of the Ca(2+)-dependent K+ channel, hslo, by the substituted diphenylurea NS 1608, paxilline and internal Ca2+.

Authors:  D Strøbaek; P Christophersen; N R Holm; P Moldt; P K Ahring; T E Johansen; S P Olesen
Journal:  Neuropharmacology       Date:  1996       Impact factor: 5.250

2.  Design, synthesis, and functional expression of a gene for charybdotoxin, a peptide blocker of K+ channels.

Authors:  C S Park; S F Hausdorff; C Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

3.  High-level expression and functional reconstitution of Shaker K+ channels.

Authors:  T Sun; A A Naini; C Miller
Journal:  Biochemistry       Date:  1994-08-23       Impact factor: 3.162

4.  Purification of charybdotoxin, a specific inhibitor of the high-conductance Ca2+-activated K+ channel.

Authors:  C Smith; M Phillips; C Miller
Journal:  J Biol Chem       Date:  1986-11-05       Impact factor: 5.157

5.  Synthesis of two peptide scorpion toxins and their use to investigate the aortic tissue regulation.

Authors:  G K Tóth; J Pataricza; T Janáky; M Mák; M Zarándi; J G Papp; B Penke
Journal:  Peptides       Date:  1995       Impact factor: 3.750

6.  Brownian dynamics simulations of interaction between scorpion toxin Lq2 and potassium ion channel.

Authors:  M Cui; J Shen; J M Briggs; X Luo; X Tan; H Jiang; K Chen; R Ji
Journal:  Biophys J       Date:  2001-04       Impact factor: 4.033

7.  A neuronal beta subunit (KCNMB4) makes the large conductance, voltage- and Ca2+-activated K+ channel resistant to charybdotoxin and iberiotoxin.

Authors:  P Meera; M Wallner; L Toro
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

8.  Engineering a uniquely reactive thiol into a cysteine-rich peptide.

Authors:  E Shimony; T Sun; L Kolmakova-Partensky; C Miller
Journal:  Protein Eng       Date:  1994-04

9.  Evolutionary trace analysis of scorpion toxins specific for K-channels.

Authors:  Shunyi Zhu; Isabelle Huys; Karin Dyason; Fons Verdonck; Jan Tytgat
Journal:  Proteins       Date:  2004-02-01

10.  Development of Ca2+-channel and BK-channel expression in embryos and larvae of Xenopus laevis.

Authors:  Cristina Jiménez-González; Gerald J McLaren; Nicholas Dale
Journal:  Eur J Neurosci       Date:  2003-10       Impact factor: 3.386

View more
  6 in total

1.  The dystrophin-associated protein complex maintains muscle excitability by regulating Ca(2+)-dependent K(+) (BK) channel localization.

Authors:  Feyza Sancar; Denis Touroutine; Shangbang Gao; Hyun J Oh; Marie Gendrel; Jean-Louis Bessereau; Hongkyun Kim; Mei Zhen; Janet E Richmond
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

2.  Synthesis of an iberiotoxin derivative by chemical ligation: a method for improved yields of cysteine-rich scorpion toxin peptides.

Authors:  Jon-Paul Bingham; Joycelyn B Chun; Margaret R Ruzicka; Qing X Li; Zhi-Yong Tan; Yuri A Kaulin; Darren R Englebretsen; Edward G Moczydlowski
Journal:  Peptides       Date:  2009-03-26       Impact factor: 3.750

3.  Interactions between β-catenin and the HSlo potassium channel regulates HSlo surface expression.

Authors:  Shumin Bian; Jun-Ping Bai; Hannah Chapin; Cathy Le Moellic; Huiping Dong; Michael Caplan; Fred J Sigworth; Dhasakumar S Navaratnam
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

4.  Structure of the BK potassium channel in a lipid membrane from electron cryomicroscopy.

Authors:  Liguo Wang; Fred J Sigworth
Journal:  Nature       Date:  2009-08-30       Impact factor: 49.962

Review 5.  Scorpion toxins specific for potassium (K+) channels: a historical overview of peptide bioengineering.

Authors:  Zachary L Bergeron; Jon-Paul Bingham
Journal:  Toxins (Basel)       Date:  2012-11-01       Impact factor: 4.546

6.  Inhibition of BKCa negatively alters cardiovascular function.

Authors:  Nishi H Patel; Justin Johannesen; Kajol Shah; Sumanta K Goswami; Neel J Patel; Devasena Ponnalagu; Andrew R Kohut; Harpreet Singh
Journal:  Physiol Rep       Date:  2018-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.